20-SOLA is an orally active 20-HETE antagonist. 20-SOLA greatly ameliorates changes in blood pressure and renal injury associated with a Streptozotocin (STZ) (HY-13753)-diabetic mouse model. 20-SOLA facilitates the restoration of coronary collateral growth (CCG) after ischemic injury. 20-SOLA can be studied for research in cardiovascular diseases and diabetes[1].
Molecular Weight:
602.84
Purity:
98.76
Formula:
C33H62O9
Target:
Cytochrome P450,Orphan Receptor
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted